AbbVie (ABBV)
Large pharmaceutical company spun off from Abbott in 2013, with immunology blockbusters Skyrizi and Rinvoq succeeding Humira, plus the Allergan aesthetics portfolio (Botox).
- Legal name
- AbbVie Inc.
- Ticker
- ABBV
- Exchange
- New York Stock Exchange · MIC XNYS
- Country
- United States
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Market cap ≈
- $390bn (approx., seed-0.6 · 2026-08-29)
- Reporting currency
- USD
- Founded
- 2013
- Website
- www.abbvie.com
- LEI
- FR5LCKFTG8054YNNRU85 (GLEIF)
- ISIN
- US00287Y1091 (check digit validated)
- FIGI
- BBG0025Y4RZ3 (share class, OpenFIGI)
Graph connections view in graph →
lists_onNew York Stock Exchange
domiciled_inUnited States
member_ofS&P 500
Sector peers — Healthcare
Eli Lilly · UnitedHealth Group · Johnson & Johnson · Merck & Co. · Thermo Fisher Scientific · Abbott
Compare: ABBV vs LLY · ABBV vs UNH · ABBV vs JNJ
Identifier crosswalk
| Standard | Value | What it answers |
|---|---|---|
| Ticker | ABBV | Venue-local shorthand — ambiguous across markets |
| MIC | XNYS | ISO 10383 — the venue |
| ISIN | US00287Y1091 | ISO 6166 — the security |
| LEI | FR5LCKFTG8054YNNRU85 | ISO 17442 — the legal entity |
| FIGI | BBG0025Y4RZ3 | OpenFIGI — instrument, share class |
| CUSIP | 00287Y109 | Derived from the US/CA ISIN, check digit verified — licensed identifier, not republished as data |
One entity, six naming systems. Each linked code opens its reverse-lookup page; the validator checks any code's check digit. CUSIP is shown because it is embedded in US/CA ISINs — we verify it, we do not redistribute CUSIP data.
Approximate reference values from public sources · seed-0.6 · 2026-08-29 · not real-time. See data & methodology.